MIN CHI: Open Payments
NPI 1922434521 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,340 in 92 payments from 22 companies in 2025. Trend: 2023 $1,243 · 2024 $1,906 · 2025 $2,340
Food & beverage: $2,340
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 10 | $332 |
| CVRx, Inc. | 11 | $310 |
| AstraZeneca Pharmaceuticals LP | 11 | $235 |
| Alnylam Pharmaceuticals Inc. | 10 | $225 |
| Novo Nordisk Inc | 6 | $210 |
| Merck Sharp & Dohme LLC | 6 | $135 |
| Actelion Pharmaceuticals US, Inc. | 5 | $128 |
| ABIOMED | 4 | $121 |
| Edwards Lifesciences Corporation | 4 | $101 |
| BridgeBio Pharma, Inc. | 4 | $80 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Barostim Neo System, WAINUA, Ozempic, AMVUTTRA, UPTRAVI, VERQUVO, ONPATTRO.
Industry payments across NY — which companies pay providers there.
